Ad-Tech Medical Instrument Corporation Dual-Sided Interhemispheric, Grid, Intraoperative, Strip, Wyler Subdural Electrodes Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Dual-Sided Interhemispheric, Grid, Intraoperative, Strip, Wyler Subdural Electrodes
Brand
Ad-Tech Medical Instrument Corporation
Lot Codes / Batch Numbers
All catalog numbers and lot numbers distributed through May 30, 2019
Products Sold
All catalog numbers and lot numbers distributed through May 30, 2019
Ad-Tech Medical Instrument Corporation is recalling Dual-Sided Interhemispheric, Grid, Intraoperative, Strip, Wyler Subdural Electrodes due to Supplemental information provided with devices indicates that the subdural electrodes, depth electrodes, and anchor bolts are approved for use in the . Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Supplemental information provided with devices indicates that the subdural electrodes, depth electrodes, and anchor bolts are approved for use in the MR environment, for which they are not approved for such use.
Recommended Action
Per FDA guidance
Ad-Tech Medical Instrument Corporation notified customers on about 06/18/2019, via "MEDICAL DEVICE RECALL" letter. The letter notified customers that the recall included supplemental information and not the actual physical device. Supplemental information includes: 1. Catalog - MKTG-3006 Product Catalog; 2. Attachment/Files: - Subdural MRI Certification, - Subdural MRI Testing Scheinder, - Subdural RF Heating Kanal, - Depth Electrode MRI Certification, - Depth MRI Testing Scheinder, - Depth RF Heating Kanal; 3. Journal Articles: Carmichael_NI_2010 - Feasibility of simultaneous intracranial EEG-fMRI in humans: A safety study, Carmichael_NI_2012 Simultaneous EEG-fMRI in humans: Protocol considerations and data quality, Vulliemoz_NI_2011 Simultaneous intracranial EEG and fMRI of interictal epileptic discharges in humans. Actions to be taken by the customer included to immediately examine records for any documentation subject to the recall for affected devices, and if any of the affected documentation has been further distributed, to identify those customers/personnel and immediately notify them of the recall. A copy of the recall notification letter can be included in that notification. Customers were also requested to complete the provided response form to acknowledge understanding that the devices are not approved for use as described in the recalled supplemental information. The response form also requested that customers acknowledge that the supplemental information has been properly destroyed and/or dispose of. The response form should be returned to the Ad-Tech Regulatory Team at FAX: 262-634-5668, Telephone: 262-634-1555, Email: Regulatory@adtechmedical.com. Questions or issues can also be directed to this team at the above contacts Monday - Friday 7:00 AM to 5:00 PM, Central Time.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026